- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04675554
Role of Psychological Factors and Acceptability of New Technology in Engaging Seniors in Physical Activity
January 23, 2023 updated by: Centre Hospitalier Universitaire de Nice
The Role of Psychological Factors and the Acceptability of New Technology in Engaging Seniors in Physical Activity: A Pilot Study
This study will be a non-interventional study intended to identify psychological antecedents of the acceptability of WeWard application among people aged 55 years and older, , and its impacts on engagement in physical activity.
Participants will be included in the study on a voluntary basis and healthy volunteers will be registered on the national volunteer database.
This study will include people aged over 55 from senior citizens associations, from patients coming for frailty consultations at the Cimiez University Hospital Centre, and from any senior living in France.
Regarding the recruitment, application users will receive a request to participate in a scientific study.
If the request is accepted, participants will fill in the non-opposition form via the application and will complete, with their smartphone, a series of psychometric questionnaires (e.g. level of physical activity, personality, motivation, perceived physical competence, new technologies acceptability, etc.).
Participants will then use the mobile application for a period of 12 weeks during which time, physical activity data provided from participants smartphone will be gathered such as the number of steps or gait speed.
Psychometric questionnaires comprising each time one item (i.e.
ecological momentary assessment) will be administered to participants randomly, in order to assess their evolution.
After the 12 weeks of using the mobile application, older people will answer to the same series of psychometric questionnaires administered at the beginning of the study.
Finally,lparticipants who will drop out the trial during this study will be contacted in order to clarify the reasons for their withdrawal.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Fréderic CHORIN, PhD
- Phone Number: 0492034924
- Email: chorin.f@chu-nice.fr
Study Contact Backup
- Name: Olivier GUERIN, PU-PH
- Phone Number: 0492034357
- Email: guerin.o@chu-nice.fr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
all person using the application
Description
Inclusion Criteria:
- signed non opposition
- > or = 55 years old
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of steps from a mobile application :
Time Frame: during 12 weeks
|
number of steps
|
during 12 weeks
|
|
walking speed from a mobile application
Time Frame: during 12 weeks
|
walking speed
|
during 12 weeks
|
|
walking distance from a mobile application
Time Frame: during 12 weeks
|
walking distance
|
during 12 weeks
|
|
change of level from a mobile application
Time Frame: during 12 weeks
|
change of level
|
during 12 weeks
|
|
Big Five Inventory
Time Frame: before and after 12 weeks of using the application.
|
Big Five Inventory: score 1 to 5 when agree, item score is 5 when disagree, item score is 1
|
before and after 12 weeks of using the application.
|
|
Perceived physical self worth
Time Frame: before and after 12 weeks of using the application.
|
Perceived physical self worth: one item score : very bad to very good
|
before and after 12 weeks of using the application.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Olivier GUERIN, PU-PH, Centre Hospitalier Universitaire de Nice
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
February 1, 2023
Primary Completion (Anticipated)
February 1, 2025
Study Completion (Anticipated)
February 1, 2025
Study Registration Dates
First Submitted
December 9, 2020
First Submitted That Met QC Criteria
December 15, 2020
First Posted (Actual)
December 19, 2020
Study Record Updates
Last Update Posted (Estimate)
January 24, 2023
Last Update Submitted That Met QC Criteria
January 23, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 20-PP-23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Motivation
-
Nourhan M.AlyAlexandria UniversityCompleted
-
University of Southern DenmarkUnknown
-
University of AmsterdamKwaliteit Forensische Zorg JeugdRecruiting
-
Temple UniversityNational Institute on Drug Abuse (NIDA)Completed
-
ThinkWellUniversity of Oxford; Queen's University, Belfast; The BMJCompleted
-
Kahramanmaras Sutcu Imam UniversityRecruiting
-
Northeastern UniversityMassachusetts General Hospital; National Institute on Aging (NIA)Unknown
Clinical Trials on Follow up of physical activity
-
Turku University HospitalTampere University Hospital; Turku University of Applied SciencesNot yet recruitingPhysical Activity During Cancer Treatment
-
Ohio State University Comprehensive Cancer CenterRecruitingBreast Carcinoma | Breast Atypical Ductal Hyperplasia | Breast Atypical Lobular Hyperplasia | Breast Lobular Carcinoma In Situ | Breast Sclerosing AdenosisUnited States
-
University Hospital, MontpellierEuropean Union; Occitanie RegionTerminatedRheumatoid ArthritisFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedBone Metastases | Cancer Survivor | Metastatic Malignant Neoplasm in the BoneUnited States
-
Hospices Civils de LyonCompleted
-
Centre Leon BerardRecruiting
-
Duke-NUS Graduate Medical SchoolCompleted
-
Inland Norway University of Applied SciencesSykehuset Innlandet HFActive, not recruiting
-
Martin FortinPfizer; Fonds de la Recherche en Santé du Québec; Centre de santé et de services... and other collaboratorsCompletedHeart Failure | Cardiovascular Disease | Diabetes | Chronic Obstructive Pulmonary Disease | AsthmaCanada
-
Universidad Central de VenezuelaThe ENose Company, Zutphen, Netherlands; Foundation for Research in Mycobacteria...UnknownTuberculosis, Pulmonary | e-NoseVenezuela